Company Spotlight

Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Company Spotlight
HIV Drugs Market Size Analysis Report - Market Share, Forecast Trends and Outlook 2025-2034
The global HIV drugs market was valued at USD 33.54 billion in 2024 and is projected to grow at a CAGR of 4.50% from 2025 to 2034, reaching approximately USD 52.09 billion by 2034. As per the analysis by Expert Market Research, the market is expected to be driven by the growing development and introduction of HIV drugs.
The market is being driven by the increasing government initiatives and campaigns, surging population density of HIV infected people, and the introduction of generic drugs in the market. Furthermore, international organisations' rising investments in R&D activities to develop efficient therapeutic solutions and advanced treatment options are aiding the industry. The industry is boosted by the presence of established healthcare facilities in North America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global HIV drugs market include ViiV Healthcare, Merck & Co. (NYSE: MRK) and Gilead Sciences, Inc. (NASDAQ: GILD). Gilead Sciences, Inc. and Merck & Co. signed an agreement in March 2021 to co-develop and co-commercialise the long-term treatment for HIV. The two companies' collaboration will provide new treatment options for HIV patients by further developing Gilead's lenacapavir and Merck's islatravir. ViiV Healthcare, in January 2021, announced the FDA approval of Cabenuva, the first and the only complete long-acting treatment for HIV-1 in adults. The drug provides virologically suppressed adults with HIV to sustain viral suppression with 12 dosing days annually. The development of innovative, inexpensive, reliable, and efficient medicines for treating HIV is aiding the market.
Headquarters: | Ingelheim am Rhein, Germany |
Establishment: | 1885 |
Website: | https://www.boehringer-ingelheim.com/ |
Boehringer Ingelheim International GmbH is a German pharmaceutical company that develops, produces and markets products of superior therapeutic value for human and veterinary medicine. The products offered by the company include Giotrif, Jardiance, OFEV, Pradaxa, Praxbind, Spiriva, and many others. It is a global leader in the prevention of diseases through vaccines and parasiticides. The company generated a revenue of about EUR 19,556 million in 2020.
Headquarters: | North Carolina, USA |
Establishment: | 2009 |
Website: | https://viivhealthcare.com/en-us/ |
ViiV Healthcare is a UK-based pharmaceutical company that was formed as a joint venture by Pfizer and GlaxoSmithKline for developing therapies for HIV disease. The company provides 16 antiretroviral medicines and a range of therapeutic options for HIV treatment. It is the second-largest healthcare company engaged in providing treatment for HIV globally. ViiV Healthcare has about 1000 employees working in 15 countries and three regional hubs.
Headquarters: | New Jersey, United States of America |
Establishment: | 1891 |
Website: | https://www.merck.com/ |
Merck & Co., Inc is an American multinational company and provides vaccinations and medicines for treating cancer, oncology, cardio-metabolic disorders, infectious diseases, HIV and Ebola, and emerging animal diseases. The company had invested over USD 13.6 billion in 2020 for research and development on finding solutions for various diseases. Merck & Co., Inc has about 74,000 employees globally. The company earned USD 47,994 million in 2020.
Headquarters: | Basel, Switzerland |
Establishment: | 1896 |
Website: | https://www.roche.com/ |
F. Hoffmann-La Roche Ltd is a Switzerland-based healthcare company and is the largest biotech company globally. The company is a global leader in providing in vitro diagnosis and cancer drugs and operates under two divisions: pharmaceuticals and diagnostics. The subsidiaries under it are Genentech, GenMark Diagnostics, Chugai Pharmaceutical Co, Spark Therapeutics, and others. It provides medicines for oncology, virology, inflammation, metabolism, blood screening, genetics, infectious diseases, and others. The company generated CHF 61,466.00 million in 2019.
Headquarters: | California, United States of America |
Establishment: | 1987 |
Website: | https://www.gilead.com/ |
Gilead Sciences, Inc. is an American biopharmaceutical company that develops and distributes therapeutics for patients suffering from severe diseases. The company offers medicines for HIV, AIDS, liver disease, oncology, COVID-19, and serious cardiovascular and respiratory conditions. These medicines include Atripla®, Biktarvy®, Descovy®, Veklury®, Viread®, Trodelvy™ and many others. The company generated product sales of USD 6.3 billion in Q1 2021.
Headquarters: | Mumbai, India |
Establishment: | 1935 |
Website: | https://www.cipla.com/ |
Cipla Inc. is an Indian pharmaceutical company that provides medicines and personal care products. The company produces active pharmaceutical ingredients and formulations in therapeutic areas, such as allergy, analgesic, anti-malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators and nutritional products. It develops over 1,500 products and has a presence in about 80 countries globally.
Headquarters: | New Jersey, United States of America |
Establishment: | 1886 |
Website: | https://www.jnj.com/ |
Johnson & Johnson Services Inc is a subsidiary of Johnson & Johnson. The company operates in more than 60 countries. It offers consumer healthcare products for hygiene, beauty, facial skin care, baby care, wound care, cough and cold, and over-the-counter products. With over 130,000 employees, the company generated worldwide sales of USD 82.584 billion in 2020.
Vishakha Agrawal
Market intelligence professional with 7+ years of experience in healthcare market research, specializing in pharmaceuticals, medical devices, and healthcare services. Skilled in data analytics, competitive intelligence, industry benchmarking, and market forecasting. Possesses expertise in analyzing patient demographics, disease prevalence, FDA approvals, and clinical trial trends. Proficient in primary (surveys, interviews, focus groups) and secondary (medical literature, white papers, healthcare databases) research. Strong knowledge of regulatory compliance (HIPAA, GDPR, EMA, CMS). Also adept at trade insights, vendor mapping, cost modelling, and supply chain analysis with experience in data visualization and reporting (Tableau, Power BI, Excel).
Latest Updates on Thriving Economically in a World of Constant Innovation
Discover the World Health Organization’s new comprehensive guidelines to fight meningitis. This ar...
President Trump’s new executive order targets high U.S. drug prices by requiring pharmaceutical co...
Top 10 Companies in the Neuroendoscopy Devices Market in 2025 - Intuitive Surgical Inc., Stryker Ind...
Top Companies in the Neuroendoscopy Devices Market, Karl Storz SE & Co. KG, B. Braun Medical Ltd., A...
A subscription-based dashboard by Expert Market Research, offering all-encompassing market intelligence.
A subscription-based dashboard by Expert Market Research, offering all-encompassing market intelligence.
A subscription-based dashboard by Expert Market Research, offering all-encompassing market intelligence.
To place an order through our website, select the license type mentioned on the report details page. Click on the ‘Buy Now’ button and fill in your details. Select your preferred mode of payment after which you will be redirected to the selected payment gateway. Follow the steps and proceed to checkout.
www.expertmarketresearch.comEnlisting all your requirements and queries along with details that include billing and delivery address and the preferred payment mode. Our customer service representative will revert to you within 24 hours.
[email protected]To place an order through telephone, call our sales team on the following numbers and our customer service representative will help you regarding the same.
+61 291 889 415Please note you will no longer be purchasing within our bundle subscription.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office) +
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia +
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India +
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines +
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom +
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam +
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
This website uses cookies to improve your experience. By clicking “Accept” you are agreeing to our Privacy Policy.
Share